Dirui Industrial Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 6.89%

Dirui Industrial Co Ltd (300396) has an Asset Resilience Ratio of 6.89% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check strategic asset allocation of Dirui Industrial Co Ltd to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥180.62 Million
≈ $26.43 Million USD Cash + Short-term Investments

Total Assets

CN¥2.62 Billion
≈ $383.65 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2013–2025)

This chart shows how Dirui Industrial Co Ltd's Asset Resilience Ratio has changed over time. See Dirui Industrial Co Ltd balance sheet independence to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Dirui Industrial Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300396 stock market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥180.62 Million 6.89%
Total Liquid Assets CN¥180.62 Million 6.89%

Asset Resilience Insights

  • Limited Liquidity: Dirui Industrial Co Ltd maintains only 6.89% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Dirui Industrial Co Ltd Industry Peers by Asset Resilience Ratio

Compare Dirui Industrial Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Cochlear Ltd
AU:COH
Medical Devices 9.76%
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
Jafron Biomedical Co Ltd
SHE:300529
Medical Devices 39.15%
HOB Biotech Group Corp Ltd
SHG:688656
Medical Devices 2.62%
Polynovo Ltd
AU:PNV
Medical Devices 0.04%
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
Medical Devices 10.88%
Emvision Medical Devices Ltd
AU:EMV
Medical Devices 0.06%
Affluent Medical SAS
PA:AFME
Medical Devices 0.03%

Annual Asset Resilience Ratio for Dirui Industrial Co Ltd (2013–2025)

The table below shows the annual Asset Resilience Ratio data for Dirui Industrial Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 6.50% CN¥180.32 Million
≈ $26.39 Million
CN¥2.77 Billion
≈ $405.64 Million
+6.50pp
2023-12-31 0.01% CN¥185.85K
≈ $27.20K
CN¥3.32 Billion
≈ $485.93 Million
-5.83pp
2022-12-31 5.83% CN¥170.61 Million
≈ $24.96 Million
CN¥2.93 Billion
≈ $428.06 Million
-11.91pp
2021-12-31 17.74% CN¥421.40 Million
≈ $61.66 Million
CN¥2.38 Billion
≈ $347.63 Million
+13.60pp
2019-12-31 4.14% CN¥85.43 Million
≈ $12.50 Million
CN¥2.06 Billion
≈ $301.78 Million
+4.13pp
2018-12-31 0.01% CN¥171.21K
≈ $25.05K
CN¥1.99 Billion
≈ $291.04 Million
0.00pp
2017-12-31 0.01% CN¥212.70K
≈ $31.12K
CN¥1.85 Billion
≈ $270.86 Million
0.00pp
2016-12-31 0.01% CN¥248.03K
≈ $36.30K
CN¥1.86 Billion
≈ $271.94 Million
0.00pp
2015-12-31 0.02% CN¥274.84K
≈ $40.22K
CN¥1.77 Billion
≈ $258.56 Million
-5.72pp
2014-12-31 5.73% CN¥60.00 Million
≈ $8.78 Million
CN¥1.05 Billion
≈ $153.17 Million
+1.15pp
2013-12-31 4.58% CN¥25.00 Million
≈ $3.66 Million
CN¥546.01 Million
≈ $79.90 Million
--
pp = percentage points

About Dirui Industrial Co Ltd

SHE:300396 China Medical Devices
Market Cap
$272.15 Million
CN¥1.86 Billion CNY
Market Cap Rank
#15411 Global
#4533 in China
Share Price
CN¥6.82
Change (1 day)
-2.99%
52-Week Range
CN¥6.76 - CN¥15.47
All Time High
CN¥36.95
About

Dirui Industrial Co., Ltd. engages in the research and development, production, and sale of medical inspection products in the People's Republic of China. The company provides medical instruments and supporting test strip reagents. It also offers urine and biochemical analysis, chemiluminescence immunoassay, gynecological secretion analysis, blood cell analysis, coagulation analysis, and integrat… Read more